Apellis Pharmaceuticals (APLS)
(Delayed Data from NSDQ)
$23.38 USD
+0.25 (1.08%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $23.38 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum A VGM
Fundamental Charts
About Dividend Yield (TTM)
Apellis Pharmaceuticals, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
APLS 23.38 +0.25(1.08%)
Will APLS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for APLS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for APLS
Apellis Pharmaceuticals (APLS) Reports Q2 Earnings: What Key Metrics Have to Say
Repligen (RGEN) Lags Q2 Earnings Estimates
APLS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Axsome Therapeutics (AXSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Sanofi's Gene Therapy for Eye Disease Gets FDA's Fast Track Tag
Apellis Stock Rises on $300M Royalty Deal With Sobi for Aspaveli
Other News for APLS
50 Day Moving Average Resistance appears for APLS after 2.9% move
Fell Below 50 Day Moving Average appears for APLS after 2.34% move
Is APLS ready to move higher? 50 Day Moving Average Support shows up after sliding 1.85%
APLS Crosses Below Key Moving Average Level
NR7 appears for APLS after 2.17% move